Cole Pinnow - May 25, 2024 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Commercial Officer
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
Stock symbol
COGT
Transactions as of
May 25, 2024
Transactions value $
$0
Form type
4
Date filed
5/29/2024, 04:03 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $0 +525K $0.00 525K May 25, 2024 Common Stock 525K $8.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest 25% on the first anniversary of May 25, 2024, with the remainder vesting in equal monthly installments through May 25, 2028, subject to the Reporting Person's continued service to the Issuer.